Literature DB >> 23300183

Identification and characterization of a novel murine allele of Tmprss6.

Thomas B Bartnikas1, Andrea U Steinbicker, Dean R Campagna, Sherika Blevins, Lanette S Woodward, Carolina Herrera, Kenneth D Bloch, Monica J Justice, Mark D Fleming.   

Abstract

Mutagenesis screens can establish mouse models of utility for the study of critical biological processes such as iron metabolism. Such screens can produce mutations in novel genes or establish novel alleles of known genes, both of which can be useful tools for study. In order to identify genes of relevance to hematologic as well as other phenotypes, we performed N-ethyl-N-nitrosourea mutagenesis in C57BL/6J mice. An anemic mouse was identified and a putative mutation was characterized by mapping, sequencing and in vitro activity analysis. The mouse strain was backcrossed for ten generations then phenotypically characterized with respect to a previously established null mouse strain. Potential modifying loci were identified by quantitative trait locus analysis. Mapping and sequencing in an anemic mouse termed hem8 identified an I286F substitution in Tmprss6, a serine protease essential for iron metabolism; this substitution impaired in vitro protease activity. After backcrossing to C57BL6/J for ten generations, the hem8(-/-) strain exhibited a phenotype similar in some but not all aspects to that of Tmprss6(-/-) mice. The hem8 and Tmprss6-null mutations were allelic. Both hem8(-/-) and Tmprss6(-/-) mice responded similarly to pharmacological modulators of bone morphogenetic protein signaling, a key regulator of iron metabolism. Quantitative trait locus analysis in the hem8 strain identified potential modifying loci on chromosomes 2, 4, 7 and 10. In conclusion, the hem8 mouse model carries a novel allele of Tmprss6. Potential uses for this strain in the study of iron metabolism are discussed.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23300183      PMCID: PMC3669439          DOI: 10.3324/haematol.2012.074617

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  48 in total

1.  A novel mutation Gly603Arg of TMPRSS6 in a Korean female with iron-refractory iron deficiency anemia.

Authors:  Hyoung Soo Choi; Hye Ran Yang; Sang Hoon Song; Ja-Young Seo; Ki-O Lee; Hee-Jin Kim
Journal:  Pediatr Blood Cancer       Date:  2011-05-25       Impact factor: 3.167

2.  Identification of the first low-molecular-weight inhibitors of matriptase-2.

Authors:  Mihiret Tekeste Sisay; Torsten Steinmetzer; Marit Stirnberg; Eva Maurer; Maya Hammami; Jürgen Bajorath; Michael Gütschow
Journal:  J Med Chem       Date:  2010-08-12       Impact factor: 7.446

3.  Down-regulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis.

Authors:  Karin E Finberg; Rebecca L Whittlesey; Mark D Fleming; Nancy C Andrews
Journal:  Blood       Date:  2010-03-03       Impact factor: 22.113

4.  Control of systemic iron homeostasis by the hemojuvelin-hepcidin axis.

Authors:  An-Sheng Zhang
Journal:  Adv Nutr       Date:  2010-11-16       Impact factor: 8.701

5.  Mutation of the gastric hydrogen-potassium ATPase alpha subunit causes iron-deficiency anemia in mice.

Authors:  Lara Krieg; Oren Milstein; Philippe Krebs; Yu Xia; Bruce Beutler; Xin Du
Journal:  Blood       Date:  2011-10-05       Impact factor: 22.113

6.  Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation.

Authors:  Andrea U Steinbicker; Chetana Sachidanandan; Ashley J Vonner; Rushdia Z Yusuf; Donna Y Deng; Carol S Lai; Kristen M Rauwerdink; Julia C Winn; Borja Saez; Colleen M Cook; Brian A Szekely; Cindy N Roy; Jasbir S Seehra; Gregory D Cuny; David T Scadden; Randall T Peterson; Kenneth D Bloch; Paul B Yu
Journal:  Blood       Date:  2011-03-10       Impact factor: 22.113

7.  The TR2 and TR4 orphan nuclear receptors repress Gata1 transcription.

Authors:  Osamu Tanabe; Yannan Shen; Qinghui Liu; Andrew D Campbell; Takashi Kuroha; Masayuki Yamamoto; James Douglas Engel
Journal:  Genes Dev       Date:  2007-11-01       Impact factor: 11.361

8.  Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways.

Authors:  Nicole Soranzo; Serena Sanna; Eleanor Wheeler; Christian Gieger; Dörte Radke; Josée Dupuis; Nabila Bouatia-Naji; Claudia Langenberg; Inga Prokopenko; Elliot Stolerman; Manjinder S Sandhu; Matthew M Heeney; Joseph M Devaney; Muredach P Reilly; Sally L Ricketts; Alexandre F R Stewart; Benjamin F Voight; Christina Willenborg; Benjamin Wright; David Altshuler; Dan Arking; Beverley Balkau; Daniel Barnes; Eric Boerwinkle; Bernhard Böhm; Amélie Bonnefond; Lori L Bonnycastle; Dorret I Boomsma; Stefan R Bornstein; Yvonne Böttcher; Suzannah Bumpstead; Mary Susan Burnett-Miller; Harry Campbell; Antonio Cao; John Chambers; Robert Clark; Francis S Collins; Josef Coresh; Eco J C de Geus; Mariano Dei; Panos Deloukas; Angela Döring; Josephine M Egan; Roberto Elosua; Luigi Ferrucci; Nita Forouhi; Caroline S Fox; Christopher Franklin; Maria Grazia Franzosi; Sophie Gallina; Anuj Goel; Jürgen Graessler; Harald Grallert; Andreas Greinacher; David Hadley; Alistair Hall; Anders Hamsten; Caroline Hayward; Simon Heath; Christian Herder; Georg Homuth; Jouke-Jan Hottenga; Rachel Hunter-Merrill; Thomas Illig; Anne U Jackson; Antti Jula; Marcus Kleber; Christopher W Knouff; Augustine Kong; Jaspal Kooner; Anna Köttgen; Peter Kovacs; Knut Krohn; Brigitte Kühnel; Johanna Kuusisto; Markku Laakso; Mark Lathrop; Cécile Lecoeur; Man Li; Mingyao Li; Ruth J F Loos; Jian'an Luan; Valeriya Lyssenko; Reedik Mägi; Patrik K E Magnusson; Anders Mälarstig; Massimo Mangino; María Teresa Martínez-Larrad; Winfried März; Wendy L McArdle; Ruth McPherson; Christa Meisinger; Thomas Meitinger; Olle Melander; Karen L Mohlke; Vincent E Mooser; Mario A Morken; Narisu Narisu; David M Nathan; Matthias Nauck; Chris O'Donnell; Konrad Oexle; Nazario Olla; James S Pankow; Felicity Payne; John F Peden; Nancy L Pedersen; Leena Peltonen; Markus Perola; Ozren Polasek; Eleonora Porcu; Daniel J Rader; Wolfgang Rathmann; Samuli Ripatti; Ghislain Rocheleau; Michael Roden; Igor Rudan; Veikko Salomaa; Richa Saxena; David Schlessinger; Heribert Schunkert; Peter Schwarz; Udo Seedorf; Elizabeth Selvin; Manuel Serrano-Ríos; Peter Shrader; Angela Silveira; David Siscovick; Kjioung Song; Timothy D Spector; Kari Stefansson; Valgerdur Steinthorsdottir; David P Strachan; Rona Strawbridge; Michael Stumvoll; Ida Surakka; Amy J Swift; Toshiko Tanaka; Alexander Teumer; Gudmar Thorleifsson; Unnur Thorsteinsdottir; Anke Tönjes; Gianluca Usala; Veronique Vitart; Henry Völzke; Henri Wallaschofski; Dawn M Waterworth; Hugh Watkins; H-Erich Wichmann; Sarah H Wild; Gonneke Willemsen; Gordon H Williams; James F Wilson; Juliane Winkelmann; Alan F Wright; Carina Zabena; Jing Hua Zhao; Stephen E Epstein; Jeanette Erdmann; Hakon H Hakonarson; Sekar Kathiresan; Kay-Tee Khaw; Robert Roberts; Nilesh J Samani; Mark D Fleming; Robert Sladek; Gonçalo Abecasis; Michael Boehnke; Philippe Froguel; Leif Groop; Mark I McCarthy; W H Linda Kao; Jose C Florez; Manuela Uda; Nicholas J Wareham; Inês Barroso; James B Meigs
Journal:  Diabetes       Date:  2010-09-21       Impact factor: 9.461

9.  The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin.

Authors:  Laura Silvestri; Alessia Pagani; Antonella Nai; Ivana De Domenico; Jerry Kaplan; Clara Camaschella
Journal:  Cell Metab       Date:  2008-10-30       Impact factor: 27.287

10.  Common variants in TMPRSS6 are associated with iron status and erythrocyte volume.

Authors:  Beben Benyamin; Manuel A R Ferreira; Gonneke Willemsen; Scott Gordon; Rita P S Middelberg; Brian P McEvoy; Jouke-Jan Hottenga; Anjali K Henders; Megan J Campbell; Leanne Wallace; Ian H Frazer; Andrew C Heath; Eco J C de Geus; Dale R Nyholt; Peter M Visscher; Brenda W Penninx; Dorret I Boomsma; Nicholas G Martin; Grant W Montgomery; John B Whitfield
Journal:  Nat Genet       Date:  2009-10-11       Impact factor: 38.330

View more
  4 in total

1.  Investigating the role of transferrin in the distribution of iron, manganese, copper, and zinc.

Authors:  Carolina Herrera; Michael A Pettiglio; Thomas B Bartnikas
Journal:  J Biol Inorg Chem       Date:  2014-02-25       Impact factor: 3.358

2.  The catalytic, stem, and transmembrane portions of matriptase-2 are required for suppressing the expression of the iron-regulatory hormone hepcidin.

Authors:  Peizhong Mao; Aaron M Wortham; Caroline A Enns; An-Sheng Zhang
Journal:  J Biol Chem       Date:  2018-12-17       Impact factor: 5.157

3.  The ectodomain of matriptase-2 plays an important nonproteolytic role in suppressing hepcidin expression in mice.

Authors:  Caroline A Enns; Shall Jue; An-Sheng Zhang
Journal:  Blood       Date:  2020-08-20       Impact factor: 22.113

4.  A competitive enzyme-linked immunosorbent assay specific for murine hepcidin-1: correlation with hepatic mRNA expression in established and novel models of dysregulated iron homeostasis.

Authors:  Patrick Gutschow; Paul J Schmidt; Huiling Han; Vaughn Ostland; Thomas B Bartnikas; Michael A Pettiglio; Carolina Herrera; James S Butler; Elizabeta Nemeth; Tomas Ganz; Mark D Fleming; Mark Westerman
Journal:  Haematologica       Date:  2014-11-25       Impact factor: 9.941

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.